Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 2/1997

01-01-1997 | Rapid communication

Premature cell ageing and evolution of diabetic nephropathy

Authors: A. Morocutti, K. A. Earle, H. P. Rodemann, G. C. Viberti

Published in: Diabetologia | Issue 2/1997

Login to get access
Metadata
Title
Premature cell ageing and evolution of diabetic nephropathy
Authors
A. Morocutti
K. A. Earle
H. P. Rodemann
G. C. Viberti
Publication date
01-01-1997
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/1997
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s001250050670

Other articles of this Issue 2/1997

Diabetologia 2/1997 Go to the issue

OriginalPaper

Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia

OriginalPaper

Incidence trends in childhood onset IDDM in four countries around the Baltic sea during 1983–1992

OriginalPaper

Effects of troglitazone on in vitro oxidation of LDL and HDL induced by copper ions and endothelial cells

OriginalPaper

Rising prevalence of NIDDM in an urban population in India

OriginalPaper

Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension

OriginalPaper

Geographic variation in mortality among individuals with youth-onset diabetes mellitus across the world
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits